A safety assessment of the antimalarial herb Artemisia annua during pregnancy in Wistar rats

Phytotherapy Research

Volumn 27, Issue 5, 2013, Pages 647-654

  Abolaji, Amos O ^a,b   Eteng, Mbeh U ^c   Ebong, Patrick E ^c   Brisibe, Ebiamadon Andi ^c   Dar, Ahsana ^a   Kabir, Nurul ^a   Choudhary, M Iqbal ^a  

^a UNIVERSITY OF KARACHI   (Pakistan)

^b UNIVERSITY OF IBADAN   (Nigeria)

^c UNIVERSITY OF CALABAR   (Nigeria)

Author keywords

Artemisia annua; artemisinin; biochemical indices; embryotoxicity; haematological indices

Indexed keywords

ARTEMISIA ANNUA EXTRACT; ESTROGEN; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTEMISIA ANNUA; ARTICLE; BLOOD ANALYSIS; BLOOD TOXICITY; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOSE RESPONSE; DRUG SAFETY; EMBRYOTOXICITY; ESTROGEN BLOOD LEVEL; FEMALE; FETUS; FETUS DEATH; FETUS MALFORMATION; FETUS WEIGHT; GESTATIONAL AGE; HYPERLIPIDEMIA; LITTER SIZE; MALE; NONHUMAN; PLANT LEAF; PREGNANCY; RAT; TOXIC HEPATITIS;

ANIMALS; ANTIMALARIALS; ARTEMISIA ANNUA; BIOLOGICAL MARKERS; EMBRYO, MAMMALIAN; FEMALE; LIVER; MATERNAL EXPOSURE; PLANT EXTRACTS; PREGNANCY; RATS; RATS, WISTAR; TOXICITY TESTS, SUBACUTE;

ANIMALIA; ARTEMISIA ANNUA; RATTUS; RATTUS NORVEGICUS;

EID: 84876472017     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4760     Document Type: Article

References (63)

1. Abdullah S, Adazu K, Masanja H, et al,. 2007. Patterns of age-specific mortality in children in endemic areas of sub-Saharan Africa. Am J Trop Med Hyg 77: 99-105.
2. Abolaji AO, Eteng MU, Ebong PE, et al,. 2010. Standardisation of Artemisia annua using Reversed Phase High Performance Liquid Chromatography (RP-HPLC). Phcog J 2 (7): 143-147.
3. Alkadi HO,. 2007. Antimalarial drug toxicity: A review. Chemotherapy 53: 385-391.
4. 2) mediated effects of high acute doses of artemisinin in rodents. Brain Res Bull 62: 255-260.
5. Barnes KI, White NJ,. 2005. Population biology and antimalarial resistance: The Transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Trop 94: 230-240.
6. Bhakuni RS, Jain DC, Sharma RP, Kumar S,. 2001. Secondary metabolites of Artemisia Artemisia annua and their biological activity. Curr Sci 80 (1): 35-48.
7. Bhakuni RS, Jain DC, Sharma RP,. 2002. Phytochemistry of Artemisia annua and the development of artemisinin-derived antimalarial agents. In Artemisia, Wright CW, (ed.). Taylor & Francis: London, UK; 211-248.
8. Boareto AC, Juliane CM, Aedra CB, et al,. 2008. Toxicity of artemisinin (Artemisia annua L.) in two different periods of pregnancy in wistar rats. Reprod Toxicol 25: 239-246.
9. Brown GD,. 2010. The Biosynthesis of Artemisinin (Qinghaosu) and the Phytochemistry of Artemisia annua L. (Qinghao). Molecules 15: 7603-7698.
10. Carbonara T, Pascalea R, Argentieri MP, et al,. 2012. Phytochemical analysis of a herbal tea from Artemisia annua L. J Pharm Biomed Anal 62: 79-86.
11. Carnat AP, Gueugnot J, Lamaison JL, Guillot J, Pourrat H,. 1985. The mugwort: Artemisia vulgaris L. and Artemisia verlotiorum Lamotte. Annales pharmaceutiques françaises 43: 397-405.
12. Celik I, Suzek H,. 2008. The hematological effects of methyl parathion in rats. J Hazard Mater 153: 1117-1121.
13. Cheng CL, Chen KJ, Shih PH, et al,. 2006. Chronic renal failure rats are highly sensitive to aristolochic acids, which are nephrotoxic and carcinogenic agents. Cancer Lett 232: 236-242.
14. Colson CR, De Broe, ME,. 2005. Kidney injury from alternative medicines. Adv Chronic Kidney Dis 12: 261-275.
15. Cyranoski D,. 2004. Campaign to fight malaria hit by surge in demand for medicine. Nature 432: 259.
16. Debelle FD, Vanherweghem JL, Nortier JL,. 2008. Aristolochic acid nephropathy: a worldwide problem. Kidney Int 74: 158-169.
17. Delabays N, Simonnet X, Gaudin M,. 2001. The genetics of artemisinin content in Artemisia annua L. and the breeding of high yielding cultivars. Curr Med Chem 8: 1795-1801.
18. Ebong PE, Eyong EU, Eteng MU, Ukwe CN,. 1999. Influence of chronic administration of chloroquin on leydig cell integrity and testosterone profile of albino Wistar rats. Afr J Reprod Health 3: 97-100.
19. Eduard U, Mojmir M, Michal D, Jana N, Ingrid B,. 2005. Developmental Toxicology-An integral part of safety evaluation of new drugs. Biomed. Pap. Med. Fac. Univ. Palacky Olomouc Czech. Repub 149 (2): 209-212.
20. Efferth T, Herrmann F, Tahrani A, Wink M,. 2011. Cytotoxic activity of secondary metabolites derived from Artemisia annua L. towards cancer cells in comparison to its designated active constituent artemisinin. Phytomedicine 18: 59-969.
21. El-Dakdoky MH,. 2009. Evaluation of the developmental toxicity of artemether during different phases of rat pregnancy. Food Chem Toxicol 47: 437-441.
22. Elford BC, Roberts MF, Philipson JD, Wilson RJM,. 1987. Potentiation of the antimalarials activity of qinghaosu by methoxylated flavones. Trans R Soc Trop Med Hyg 81: 434-436.
23. Gordi T, Lepist EI,. 2004. Artemisinin derivatives. Toxic for laboratory animals, safe for human? Toxicol Lett 147: 99-107.
24. Ginsburg H, Deharo E,. 2011. A call for using natural compounds in the development of new antimalarial treatments-an introduction Malaria Journal 10 (Suppl 1): S1.
25. Grance SR, Maria AT, Roseana SL, et al,. 2008. Baccharis trimera: Effect on hematological and biochemical parameters and hepatorenal evaluation in pregnant rats. J Ethnopharmacol 117: 28-33.
26. Hasheminia SM, Sendi JJ, Jahromi KT, Moharramipour S,. 2011. The effects of Artemisia annua L. and Achillea millefolium L. crude leaf extracts on the toxicity, development, feeding efficiency and chemical activities of small cabbage Pieris rapae L. (Lepidoptera: Pieridae). Pest Biochem Physiol 99: 244-249.
27. Holm Y, Laasko I, Hitunen R, Galambosi B,. 1997. Variation in the essential oil composition of Artemisia annua L. of different origin cutivated in Finland. Flavour Fragr J 12: 241-246.
28. Klayman DL,. 1985. Qinghaosu (artemisinin) an antimalarial drug from China. Science 223: 1049-1055.
29. Lari YH, Khavarinejad RA, Roustalan AH,. 2002. The composition of essential oil from Artemisia annua L. growing wild in Iran. Falsnamah-i-Giyahan- i Daruyi 1: 41-48.
30. Longo M, Zannoncelli S, Manera D,. 2006. Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryo in vitro. Reprod Toxicol 21 (1): 83-93.
31. Mboera LE, Makundi EA, Kitua AY,. 2007. Uncertainty in malaria control in Tanzania: crossroads and challenges for future interventions. Am J Trop Med Hyg 77: 112-118.
32. Menendez C, D'Alessandro U, Kuile FO,. 2007. Reducing the burden of malaria in pregnancy by preventive strategies. Lancet Infect Dis 7: 126-135.
33. Mueller MS, Karhagomba IB, Hirt HM, Wemakor E,. 2000. The potential of Artemisia annua L. as a locally produced remedy for malaria in the tropics: agricultural, chemical and clinical aspects. J Ethnopharmacol 73: 487-493.
34. Nader R, Russell W, Alan R,. 2008. Lipids, lipoproteins, apolipoproteins, and other cardiovascular risk factors. In Tiez Fundamentals of Clinical Chemistry, Burtis CA, Edward R, David EB, (eds). Elsevier Publisher: New Delhi-110065, 402-430. ISBN: 978-0-7216-3865-2
35. Parvez S, Parvez SH, Youdim MB,. 1975. Variation in activity of monoamine metabolizing enzymes in rat liver during pregnancy. Br J Pharmacol 53 (2): 241-246.
36. Perazzo FF, Carvalho JCT, Carvalho JE, Rehder VLG, 2003. Central properties of the essential oil and the crude ethanol extract from aerial parts of Artemisia annua L. Pharmacol Res 48: 497-502.
37. Qigui L, Weina PJ,. 2010. Severe Embryotoxicity of Artemisinin Derivatives in Experimental Animals, but Possibly Safe in Pregnant Women. Molecules 15: 40-57.
38. Randy LR, Ernest H,. 2004. Metabolism of toxicants. In A textbook of Modern toxicology, 3rd edn, Hodgson E, (ed.). John Willey and Sons. Inc.: New York, 111-148. ISBN: 0-471-26508-X
39. Rasoanaivo P, Wright CW, Willcox M, Gilbert B,. 2011. Whole plant extracts versus single compounds for the treatment of malaria: synergy and positive interactions. Malaria Journal 10 (Suppl 1): S4.
40. Rath K, Taxis K, Walz G, Gleiter CH, Li SM, Heide L, 2004. Pharmacokinetic study of artemisinin after oral intake of a traditional preparation of Artemisia annua L. (annual wormwood). Am J Trop Med Hyg 70: 128-132.
41. RCOG. 2007. Antenatal care; Routine care for pregnant woman. National collaborating Centre for Women's and children's health commission, Chapter 8. National Institute for Clinical Excellence RCOG press: 27 sussex place, Regent's park, London; 67-68. www.rcog.org/resouces/public/pdf/antenatalcare.pdf
42. Rezelman D, Goris H,. 2008. Sichuan Institute of Chinese Materia Medica, Chongqing in: The role of herbal products containing Artemisia annua in malaria treatment. A proposal for further research. Concept 01 Oct. 08 Dirk Rezelman & Henk Goris. Available from: http://artemisia-for-all.org/wordpress/ wpcontent/uploads/The-role-of-herbal-products-containing-Artemisia-annua-in- malaria-treatment.-A-proposal-for-further-research.pdf
43. Robert A, Benit-Vical F, Dechy-Cabaret O, Meunier B,. 2001. From classical antimalarial drugs to new compounds based on the mechanism of action of artemisinin. Pure Appl Chem 73 (7): 1173-1188.
44. Saad B, Azaizeh H, Abu-Hijleh G, Said O,. 2006. Safety of traditional Arab herbal medicine. Evid Based Complement Altern Med 3: 433-439.
45. Schmuck G, Klaus AM, Krotlinger F, Langewische FW,. 2009. Developmental and reproductive toxicity studies on artemisone. Birth Defects Res B Dev Reprod Toxicol 86 (2): 131-143.
46. Snow RW, Trappe JF, Marsh K,. 2005. The past, present and future of childhood malaria mortality in Africa. Trends Parasitol 17: 593-597.
47. Stacy B,. 2004. Reproductive system. In A Textbook of Modern Toxicology, 3rd edn, Hodgson E, (ed.). John Willey and Sons: New York; 343-349.
48. Stermitz FR, Scriven LN, Tegos G, Lewis K,. 2002. Two flavanols from Artemisia annua which potentiate the activity of berberine and norfloxacin against a resistant strain of Staphylococcus aureus. Planta Med 68: 1140-1141.
49. Sundar SN, Marconett CN, Doan VB, Willoughby JA, Firestone GL,. 2008. Artemisinin selectively decreases functional levels of estrogen receptor-alpha and ablates estrogen-induced proliferation in human breast cancer cells. Carcinogenesis 29 (12): 2252-2258.
50. Tennant BC,. 1997. Hepatic function. In Clinical biochemistry of domestic animals, Kaneko JJ, Harvey JW, Bruss ML, (eds). Academic Press: San Diego; 327-352.
51. Tsutsumi K, Kotegawa T, Matsuki S, et al,. 2001. The effect of pregnancy on cytochrome P4501A2, xanthine oxidase, and N -acetyltransferase activities in humans. Clin Pharmacol Ther 70: 121-125.
52. University of Maryland at Baltimore. 1997. Estrogen Maintains Pregnancy, Triggers Fetal Maturation. Science Daily. Available from: http://www. sciencedaily.com/releases/1997/03/970321141042.htm (accessed 29 January 2011).
53. US EPA- US. 1991. Environmental Protection Agency. Guidelines for reproductive toxicity risk assessment. EPA/600/FR-91/001. Washington, D.C.
54. US EPA- US. 1996. Environmental Protection Agency. Guidelines for reproductive toxicity risk assessment. EPA/630/R-96009. Washington, D.C.
55. Veiga-Junior VF, Pinto AC, Maciel MA,. 2005. Medicinal plants: safe cure? Quim. Nova 28: 519-528.
56. White TE, Bushidid PB, Ritter S, Laffan SB, Clark RL,. 2006. Artesunate -induced depletion of embryonic erythroblasts precedes embryolethality and teratogenicity in vivo. Birth Defects Res B Dev Reprod Toxicol 77: 413-429.
57. Willcox M,. 2010. Clinical efficacy and safety of herbal Artemisia annua preparations: an update. 2nd International Conference on Fighting Malaria in Africa and Artemisia annua Infusion, organized by ICEI, Rome, April 23, 2010.
58. Willcox M, Bodeker G,. 2000. Plant-based malaria control: research initiative on traditional antimalarial methods. Parasitol Today 16: 220-221.
59. Willcox M, Burton S, Oyweka R, Namyalo R, Challand S, Lindsey K,. 2011. Evaluation and pharmacovigilance of projects promoting cultivation and local use of Artemisia annua for malaria. Malar J 10: 84.
60. World Health Organisation. 2001. Management of uncomplicated malarial and the use of drugs for the protection of travelers. WHO Informed consultation Report 2001, WHO/MAL/96, 1075, pp. 18-21.
61. World Health Organisation. 2006. WHO forecast. In Artepal, the portal of information and orientation on malaria and its treatments with ACT, Bangkok.
62. World Health Organisation, 2010. Guidelines for the treatment of malaria, 2nd edn. World Health Organisation: Geneva.
63. Wu CJ, Chen LC, Kuo ML,. 2006. Attenuated Salmonella typhimurium reduces ovalbumin-induced airway inflammation and T-helper type 2 responses in mice. Clin Exp Immunol 145: 116-122.